Amphix Bio Secures $12.5M Seed Funding For Peptide Drug Platform
18 Dec 2025 //
PR NEWSWIRE
Amphix Bio Gets FDA Orphan Status for Spinal Cord Injury Therapy
16 Jul 2025 //
PR NEWSWIRE
Amphix Bio Receives Federal & Grants for Regenerative Therapies
31 Oct 2024 //
PR NEWSWIRE

Market Place
Sourcing Support